Testing effectiveness (Phase 2)Study completedNCT03834948What this trial is testingAO-176 in Multiple Solid Tumor MalignanciesWho this might be right forSolid Tumor Arch Oncology 57
Early research (Phase 1)Study completedNCT04052971What this trial is testingTo Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of ABN401 in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer Harboring c-MET DysregulationWho this might be right forAdvanced Solid Tumors Abion Inc 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT06858618What this trial is testingFCN-338 in Combination With Azacitidine or Chemotherapy in Myeloid NeoplasmsWho this might be right forSafetyAntitumor ActivityPK Profile Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 47
Early research (Phase 1)Study completedNCT02221960What this trial is testingEvaluate MEDI6383 Alone and in Combination With MEDI4736 in Adult Subjects With Select Advanced Solid TumorsWho this might be right forRecurrent or Metastatic Solid Tumors MedImmune LLC 39
Early research (Phase 1)Not Yet RecruitingNCT07797907What this trial is testingThis Clinical Study is to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Antitumor Activity of BD200 in Participants With Advanced or Metastatic Cancer.Who this might be right forSolid Tumor (Phase I) Biolojic Design Ltd. 110
Early research (Phase 1)WithdrawnNCT01130623What this trial is testingA Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid TumorsWho this might be right forSarcomaNeuroblastomaWilms Tumor+2 more National Cancer Institute (NCI)
Early research (Phase 1)Looking for participantsNCT06375044What this trial is testingStudy of SIM0500 Alone in Participants With Relapsed or Refractory Multiple MyelomaWho this might be right forRelapsed or Refractory Multiple Myeloma Jiangsu Simcere Pharmaceutical Co., Ltd. 130
Testing effectiveness (Phase 2)Study completedNCT04570839What this trial is testingCOM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors.Who this might be right forEndometrial NeoplasmsOvarian CancerSolid Tumor+1 more Compugen Ltd 48
Early research (Phase 1)WithdrawnNCT05262842What this trial is testingJS001+IMP4297 in Patients With Advanced CancerWho this might be right forAdvanced Cancer Shanghai Junshi Bioscience Co., Ltd.
Early research (Phase 1)Looking for participantsNCT06241898What this trial is testingA First-in-human of Multiplle Doses of BB-1709 in Subjects With Locally Advanced/Metastatic Solid TumorsWho this might be right forSolid Tumor Bliss Biopharmaceutical (Hangzhou) Co., Ltd 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT06399757What this trial is testingInvestigate APL-5125 in Adults With Advanced Solid TumorsWho this might be right forColorectal CancerCholangiocarcinomaAppendiceal Adenocarcinoma+6 more Apollo Therapeutics Ltd 100
Testing effectiveness (Phase 2)Ended earlyNCT03361228What this trial is testingEvaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid TumorsWho this might be right forSolid Tumors Incyte Corporation 5
Early research (Phase 1)Study completedNCT07040943What this trial is testingClinical Trial of IL - 22BP Safety, Tolerability, and Antitumor Activity in Refractory Solid Tumors.Who this might be right forRefractory Malignant Solid TumorsmRNA VaccineInterleukin West China Hospital 6
Testing effectiveness (Phase 2)Study completedNCT03781934What this trial is testingEvaluate MIV-818 in Patients With Liver Cancer ManifestationsWho this might be right forHepatocellular CarcinomaIntrahepatic CholangiocarcinomaLiver Metastases Medivir 53
Early research (Phase 1)WithdrawnNCT05905341What this trial is testingStudy of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors.Who this might be right forBreast CancerOvarian CancerLiposarcoma+3 more Pfizer
Early research (Phase 1)Ended earlyNCT04178460What this trial is testingNiraparib Combined With MGD013 in Patients With Advanced or Metastatic Solid Tumor Who Failed Prior TreatmentWho this might be right forGastric CancerTriple Negative Breast CancerBiliary Tract Carcinoma+1 more Zai Lab (Shanghai) Co., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT04068519What this trial is testingStudy Investigating Safety, Tolerability, Pharmacokinetics (PK) and Antitumor Activities of Anti-PD-1 (Programmed Death-1) Monoclonal AntibodyWho this might be right forAdvanced Solid Tumors BeiGene 300
Testing effectiveness (Phase 2)Ended earlyNCT00459901What this trial is testingStudy of the Antitumor Activity of Capecitabine in Combination With Erlotinib in Patients With Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Peter Kozuch 13
Early research (Phase 1)Study completedNCT02978755What this trial is testingFirst In Human Safety, Pharmacokinetics and Anti-tumoral Activity of GM102 in Gynecological CancersWho this might be right forNeoplasm, Gynecologic GamaMabs Pharma 78
Early research (Phase 1)Looking for participantsNCT07703878What this trial is testingEvaluate the Safety and Antitumor Activity of GS-1206 in Adults With Solid TumorsWho this might be right forSolid Tumor Gilead Sciences 302